Does TENAPANOR Cause Hospitalisation? 138 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Hospitalisation have been filed in association with TENAPANOR (IBSRELA). This represents 7.1% of all adverse event reports for TENAPANOR.
138
Reports of Hospitalisation with TENAPANOR
7.1%
of all TENAPANOR reports
25
Deaths
138
Hospitalizations
How Dangerous Is Hospitalisation From TENAPANOR?
Of the 138 reports, 25 (18.1%) resulted in death, 138 (100.0%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENAPANOR. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does TENAPANOR Cause?
Diarrhoea (793)
Death (222)
Inappropriate schedule of product administration (115)
Off label use (94)
Product use issue (72)
Nausea (59)
Abdominal distension (52)
Therapy interrupted (52)
Abdominal pain (50)
Product use in unapproved indication (47)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which TENAPANOR Alternatives Have Lower Hospitalisation Risk?
TENAPANOR vs TENECTEPLASE
TENAPANOR vs TENELIGLIPTIN
TENAPANOR vs TENIPOSIDE
TENAPANOR vs TENOFOVIR
TENAPANOR vs TENOFOVIR ALAFENAMIDE